section name header

Pronunciation

eye-ver-MEK-tin

Classifications

Therapeutic Classification: anthelmintics

Pharmacologic Classification: avermectins

Indications

REMS


Action

  • Binds selectively and with a high affinity to chloride channels in invertebrate nerve and muscle cells, resulting in parasite paralysis and death.
  • Active against Strongyloides stercoralis and the nemotode form of Onchocerca volvulus.
  • Mechanism in treating rosacea unknown.
Therapeutic effects:
  • Death of infecting parasites with resolution of symptoms of infection.
  • Reduction in inflammatory lesions of rosacea.

Pharmacokinetics

Absorption: Some absorption follows oral administration; fat enhances absorption; little systemic absorption with topical administration.

Distribution: Small amounts enter breast milk.

Metabolism/Excretion: Metabolized by the liver by the CYP3A4 isoenzyme; parent drug and metabolites excreted mainly in feces; <1% excreted unchanged in urine.

Half-Life: Oral: 18 hr; Cream: 6.5 days.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown4 hrunknown
Topicalunknownunknownunknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: burning sensation (topical), dry skin (topical), pruritus, rash, urticaria

EENT: conjunctivitis (topical)

GI: abdominal pain, anorexia, constipation, diarrhea, nausea, vomiting

Neuro: COMA, confusion, disorentation, dizziness, drowsiness, fatigue, stupor, tremor, vertigo, weakness

Misc: Mazzotti reaction (onchocerciasis only), DEATH

Interactions

Drug-drug:

Route/Dosage

Strongyloidiasis

Onchocerciasis

Head Lice

Rosacea

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Sklice, Soolantra, Stromectol

Canadian Brand Names

Rosiver

Code

NDC Code